{"id":998155,"date":"2026-08-26T08:08:53","date_gmt":"2026-08-26T12:08:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/"},"modified":"2026-08-26T08:08:53","modified_gmt":"2026-08-26T12:08:53","slug":"odyssey-therapeutics-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Aug.  26, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qS2j_i9VyStm8MUHtVeJh8rDnFGsuLHsxPq3DdhDkSUqMAicl1yFz_lVrcPFWjOmoXXgW88lnlDPaNVehpysCfg6LVvnrGljyBUIp422zGE=\" rel=\"nofollow\" target=\"_blank\">Odyssey Therapeutics, Inc.<\/a> (Nasdaq: ODTX) (\u201cOdyssey\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>2026 Cantor Global Healthcare Conference<\/strong><br \/>\n          <br \/>\n          <strong>Conference Dates:<\/strong> September 9-11, 2026<br \/><strong>Location:<\/strong> New York, NY<br \/><strong>Fireside Chat:<\/strong> September 9<sup>th<\/sup> at 8:35AM ET<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>Morgan Stanley 24th Annual Global Healthcare Conference<\/strong><br \/>\n          <br \/>\n          <strong>Conference Dates:<\/strong> September 14-16, 2026<br \/><strong>Location:<\/strong> New York, NY<br \/><strong>Fireside Chat:<\/strong> September 14<sup>th<\/sup> at 10:45AM ET<\/li>\n<li style=\"margin-bottom:8pt\">\n          <strong>H.C. Wainwright 28th Annual Global Investment Conference<\/strong><br \/>\n          <br \/>\n          <strong>Conference Dates:<\/strong> September 14-16, 2026<br \/><strong>Location:<\/strong> New York, NY<br \/><strong>Fireside Chat:<\/strong> September 15<sup>th<\/sup> at 1:00PM ET<\/p>\n<\/li>\n<\/ul>\n<p>Where available, live webcasts will be available under \u201cNews and Events\u201d in the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hCJtM30Ch5Jbqg0cY3GBRXF17MsuWoq1udxIPaWJCIruROAnQRFn7H_T_m8AkYpmADc2_8SAvhN5-cIxEIDz00wSbs0A87hYVDe2xo3lbxY=\" rel=\"nofollow\" target=\"_blank\">www.odysseytx.com<\/a>. Replays of the webcasts will be made available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9-BEYSLnJAuTvFdU-2BOGDk5BwLfK1T9IOb2p28CGNB-y3QqWtZRB82ABeoQWmlN7TKq728AmcZH22FytGqm15qA90nEgxiurV_xrpBk4Ig6MLh-6ldXxSKCRptj73jO\" rel=\"nofollow\" target=\"_blank\">Events<\/a> page of Odyssey\u2019s investor website and archived for 60 days.<\/p>\n<p>\n        <strong>About Odyssey Therapeutics<\/strong>\n      <\/p>\n<p>Odyssey Therapeutics is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology. Since its founding in 2021, Odyssey has built a portfolio of internally discovered and developed medicines with its first program advancing through multiple clinical milestones. Odyssey\u2019s portfolio leverages the scientific expertise of its team of experienced drug hunters and a comprehensive suite of tools to efficiently advance product candidates that the Company believes have the potential to induce deep and durable remission for patients across several inflammatory diseases with unmet need.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g1CTSJM8X5dH5mlJcZQeD91fIMMn-kMvl6bh1O4ZQKhHNFMnPr9y8L_Z6FgzAMDVJdEEeEcMN1RN3f8PXj_1gtfz1KiUQmGImBVCwh0AmkQ=\" rel=\"nofollow\" target=\"_blank\">https:\/\/odysseytx.com\/<\/a> and follow Odyssey on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fAaX3IFO-P9U9WgO0bCuRbTgzyNHg8MBL5oqLhCzOWIZ0z-37f8dGX97HyFzjk0035uV_yf1GNDfxB1Plrh2g5apEF9lt0lqavmt8zOyvJXtBBo7WdCIAaaX-enCB8eKNTOOBP3DyD5EEMLOCMEmHg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6gCvTo4Jg6v9F1yfTv0Odv8y8q6wzTuVN9SM0U29KiM_ANEfH-WEnU7d7CIRMB0e0g3MymxbUu6Wk-JtM-5nog==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Collin Todd<br \/>SVP, Strategy and Business Development<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9WZrVzwH6lVci6ikH57Z4Dpnpqg6GrctJjodDFV_E2PnnhiXBfiFduWFn4C2fNp-8SwY0XBkZGvGm9UpvlzLIIE2OzTTbwJvUdLAvALoarQ=\" rel=\"nofollow\" target=\"_blank\">investors@odysseytx.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmEzYzQ4ZTAtNTMzZi00ODZmLTk4ZDYtY2MyM2ZjODE4MzRjLTEzMjE0OTctMjAyNi0wOC0yNi1lbg==\/tiny\/Odyssey-Therapeutics-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (\u201cOdyssey\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September: 2026 Cantor Global Healthcare Conference Conference Dates: September 9-11, 2026Location: New York, NYFireside Chat: September 9th at 8:35AM ET Morgan Stanley 24th Annual Global Healthcare Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 14th at 10:45AM ET H.C. Wainwright 28th Annual Global Investment Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 15th at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Odyssey Therapeutics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998155","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (\u201cOdyssey\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September: 2026 Cantor Global Healthcare Conference Conference Dates: September 9-11, 2026Location: New York, NYFireside Chat: September 9th at 8:35AM ET Morgan Stanley 24th Annual Global Healthcare Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 14th at 10:45AM ET H.C. Wainwright 28th Annual Global Investment Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 15th at &hellip; Continue reading &quot;Odyssey Therapeutics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T12:08:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Odyssey Therapeutics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-08-26T12:08:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\",\"datePublished\":\"2026-08-26T12:08:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Odyssey Therapeutics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (\u201cOdyssey\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that precisely target disease pathology, today announced that members of its management team will participate in the following upcoming investor conferences in September: 2026 Cantor Global Healthcare Conference Conference Dates: September 9-11, 2026Location: New York, NYFireside Chat: September 9th at 8:35AM ET Morgan Stanley 24th Annual Global Healthcare Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 14th at 10:45AM ET H.C. Wainwright 28th Annual Global Investment Conference Conference Dates: September 14-16, 2026Location: New York, NYFireside Chat: September 15th at &hellip; Continue reading \"Odyssey Therapeutics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-26T12:08:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences","datePublished":"2026-08-26T12:08:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/"},"wordCount":310,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/","name":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=","datePublished":"2026-08-26T12:08:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjIzNSM3ODAzMjI5IzIzMDk5NDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998155"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998155\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}